We are live on
!
Find out more
CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Est. Return
135.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.29%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
+$529M
(+3.7%)
Cap. Flow
-$730M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
19.19%
Holding
388
New
75
Increased
92
Reduced
120
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$100M |
| 2 |
McKesson
MCK
|
+$96.3M |
| 3 |
Deckers Outdoor
DECK
|
+$91.8M |
| 4 |
STJ
St Jude Medical
STJ
|
+$83.4M |
| 5 |
CME Group
CME
|
+$82.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$194M |
| 2 |
Union Pacific
UNP
|
+$159M |
| 3 |
Goldman Sachs
GS
|
+$136M |
| 4 |
PPLI
People Inc
PPLI
|
+$110M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.86% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Technology | 15.02% |
| 4 | Industrials | 12.03% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Allot
ALLT
$383M
| $4.71M | 0.03% |
+311,450
| New | +$4.23M |
|
252
Charles River Laboratories
CRL
$12.8B
| $4.66M | 0.03% |
+87,871
| New | +$4.41M |
|
253
Radian Group
RDN
$4.93B
| $4.53M | 0.03% |
321,040
-2,910,428
| -90% | -$40.7M |
|
254
Trip.com Group
TCOM
$29.1B
| $4.38M | 0.03% |
176,492
+79,894
| +83% | +$2.08M |
|
|
GTAT
255
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $4.34M | 0.03% |
+497,660
| New | +$4.42M |
|
|
ROSE
256
DELISTED
ROSETTA RESOURCES INC
ROSE
| $3.73M | 0.03% |
77,610
+72,583
| +1,444% | +$3.91M |
|
|
ZINC
257
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $2.99M | 0.02% |
+184,650
| New | +$2.56M |
|
|
AEGR
258
DELISTED
Aegerion Pharmaceuticals
AEGR
| $2.75M | 0.02% |
38,722
-283,479
| -88% | -$21.7M |
|
|
CAMP
259
DELISTED
CalAmp Corp.
CAMP
| $2.73M | 0.02% |
+4,251
| New | +$2.37M |
|
260
Vanda Pharmaceuticals
VNDA
$302M
| $2.44M | 0.02% |
196,358
+155,951
| +386% | +$1.57M |
|
|
CYNO
261
DELISTED
Cynosure, Inc. Class A
CYNO
| $2.17M | 0.01% |
81,539
-87,876
| -52% | -$2.11M |
|
262
Curis
CRIS
$7.83M
| $1.55M | 0.01% |
275
-41
| -13% | -$281K |
|
|
OREX
263
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.55M | 0.01% |
27,515
-78,705
| -74% | -$4.42M |
|
|
ARRY
264
DELISTED
Array Biopharma Inc
ARRY
| $1.25M | 0.01% |
248,405
-179,246
| -42% | -$976K |
|
|
MZOR
265
DELISTED
Mazor Robotics Ltd.
MZOR
| $1.18M | 0.01% |
+60,183
| New | +$1.11M |
|
|
ACOR
266
DELISTED
Acorda Therapeutics
ACOR
| $1.17M | 0.01% |
334
-448
| -57% | -$1.75M |
|
|
QIWI
267
DELISTED
QIWI PLC
QIWI
| $947K | 0.01% |
+16,915
| New | +$756K |
|
|
GNMK
268
DELISTED
GenMark Diagnostics, Inc
GNMK
| $931K | 0.01% |
70,022
-4,560
| -6% | -$55.4K |
|
269
Cytokinetics
CYTK
$10.4B
| $910K | 0.01% |
140,067
-51,255
| -27% | -$337K |
|
270
Ventas
VTR
$47.9B
| $901K | 0.01% |
13,775
-8,116
| -37% | -$564K |
|
271
Option Care Health
OPCH
$3.56B
| $783K | 0.01% |
26,470
-11,970
| -31% | -$338K |
|
|
PRXL
272
DELISTED
Parexel International Corp
PRXL
| $783K | 0.01% |
+17,333
| New | +$793K |
|
273
GE Aerospace
GE
$384B
| $727K | 0.01% |
5,409
+1,044
| +24% | +$131K |
|
|
WMGI
274
DELISTED
Wright Medical Group Inc
WMGI
| $676K | ﹤0.01% |
22,011
-4,180
| -16% | -$118K |
|
|
BEAT
275
DELISTED
BioTelemetry, Inc.
BEAT
| $646K | ﹤0.01% |
81,360
-862,827
| -91% | -$8.05M |
|
Similar funds
SWM
LCM
HCMNY
BII
HCM
DBC
DK
AVAX
Columbus Circle Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Columbus Circle Investors held 388 positions worth $14.6B, up 3.7% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Columbus Circle Investors withdrew a net $730M in Q4 2013, closing 100 positions and reducing 120 holdings. Its most notable exit was Cisco, an estimated $194M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Columbus Circle Investors opened a new position in Bristol-Myers Squibb worth $105M.
- Columbus Circle Investors's largest Q4 2013 buy was Bristol-Myers Squibb: 1,970,174 shares worth $105M.
- Columbus Circle Investors added most to Morgan Stanley in Q4 2013, an estimated $74.7M increase.
- Columbus Circle Investors's biggest Q4 2013 reduction was Capri Holdings, cutting an estimated $77.6M.
- Columbus Circle Investors fully exited Cisco in Q4 2013, selling an estimated $194M.
- Columbus Circle Investors's ten largest holdings make up 19% of its $14.6B portfolio in Q4 2013.
- Columbus Circle Investors opened 75 new positions and closed 100 in Q4 2013.
- Columbus Circle Investors's portfolio value rose 3.7% quarter-over-quarter to $14.6B.
Based on Columbus Circle Investors's 13F filing for Q4 2013, filed 5 Feb 2014.